Insulet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. 

CEO
Ashley A. McEvoy
CEOAshley A. McEvoy
Employees
5,400
Employees5,400
Headquarters
Acton, Massachusetts
HeadquartersActon, Massachusetts
Founded
2000
Founded2000
Employees
5,400
Employees5,400

PODD Key Statistics

Market cap
16.67B
Market cap16.67B
Price-Earnings ratio
69.25
Price-Earnings ratio69.25
Dividend yield
Dividend yield
Average volume
1.11M
Average volume1.11M
High today
$238.94
High today$238.94
Low today
$233.29
Low today$233.29
Open price
$238.43
Open price$238.43
Volume
1.20M
Volume1.20M
52 Week high
$354.88
52 Week high$354.88
52 Week low
$230.05
52 Week low$230.05

Stock Snapshot

Insulet(PODD) stock is priced at $237.01, giving the company a market capitalization of 16.67B. It carries a P/E multiple of 69.25.

As of 2026-03-06, Insulet(PODD) stock has fluctuated between $233.29 and $238.94. The current price stands at $237.01, placing the stock +1.6% above today's low and -0.8% off the high.

Insulet(PODD) shares are trading with a volume of 1.2M, against a daily average of 1.11M.

In the last year, Insulet(PODD) shares hit a 52-week high of $354.88 and a 52-week low of $230.05.

In the last year, Insulet(PODD) shares hit a 52-week high of $354.88 and a 52-week low of $230.05.

PODD News

TipRanks 2d
Insulet Finalizes Severance Terms for Departing CFO

Insulet ( (PODD) ) just unveiled an update. On February 27, 2026, Insulet Corporation entered into a severance agreement with former Chief Financial Officer An...

Simply Wall St 6d
Strong Revenue Growth And Upbeat 2026 Outlook Might Change The Case For Investing In Insulet

In February 2026, Insulet Corporation reported fourth-quarter 2025 sales of US$783.8 million and full-year revenue of US$2.71 billion, with annual net income of...

Strong Revenue Growth And Upbeat 2026 Outlook Might Change The Case For Investing In Insulet

Analyst ratings

93%

of 29 ratings
Buy
93.1%
Hold
3.4%
Sell
3.4%

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.